VILINBIO logo

Vilin Bio Med Limited

VILINBIO·NSE·
₹53.25▼ -1.40 (-2.56%)
Market Cap81.21 Cr
PE Ratio38.87
Volume16,000
Day High - Low55.95 - 53.25
52W High-Low60.95 - 18.95

Vilin Bio Med Limited (VILINBIO): company summary

The company's business has improved significantly, with annual revenue rising 185.3% and annual net profit jumping 777.3%.

Vilin Bio Med Limited (VILINBIO) is a micro-cap Healthcare company valued at ₹81 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Vilin Bio Med Limited last traded at ₹53.25, down 2.56% on the day.
Recent developments
On 2026-06-30, promoter holding fell by 2.92 percentage points to 56.65%. There are no recent developments reported.
Financial performance
The company's business has improved significantly, with annual revenue rising 185.3% and annual net profit jumping 777.3%. The latest quarter saw revenue surge 215.9% and net profit explode 1680.0% compared to the same quarter a year earlier. The net profit margin widened 3.1 percentage points to 4.6%, while return on equity and return on capital employed stood at 6.8% and 10.2% respectively.
Valuation multiples
The stock trades at 38.9 times earnings, a premium to the Healthcare median of 32.0, 3.17 times book value.
Things to watch
The stock is 7.3% below its 52-week high. The company is not paying out dividend despite reporting repeated profits.
Where it stands
The company has delivered strong growth in both revenue and net profit, with the latest quarter showing a dramatic increase. Promoter holding has decreased slightly, and the stock is trading below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
6.80%
Weak
P/E
38.87x
Expensive
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹53.25
₹55.95
52W₹18.95
₹60.95
DocStoX take

Supported by growth (10.0) and momentum (7.5), but held back by valuation (0.9). Growth looks strong at 10.0, but that is offset by valuation at 0.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.3
/10
Weak
Quality
Modest
ROE 6.8%
Valuation
Expensive
P/E 38.9×
Growth
Strong
Revenue +29.6% 5Y CAGR
Risk
Moderate
D/E 0.01
Momentum
Strong
82% of 52-week range

At a glance

Market Cap
₹81 Cr
52W High / Low
₹61 / ₹19
Dividend Yield
0.00%
Promoter Holding
56.65%
EPS (TTM)
₹1.37
Book Value
₹18.60

Key highlights

  • Profit compounding 74% a year
  • Low leverage — D/E 0.01
  • Revenue compounding 30% a year
  • Valuation is weak (0.9/10)
  • Small ₹81 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Vilin Bio Med Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.